NCT03004248
- Conditions
- Glabellar Frown Lines
- Locations
-
- Birmingham, Alabama, United States
- Beverly Hills, California, United States
- Encinitas, California, United States
- Fremont, California, United States
Clinical trial condition
Glabellar Frown Lines
Explore clinical trials studying Glabellar Frown Lines. Study availability and eligibility vary by location and protocol.
52 public trials
1 recruiting study
Glabellar Frown Lines trial results
NCT05059587
- Conditions
- Glabellar Frown Lines
- Locations
-
- Chung-Ang Univ. Hospital Seoul, Dongjak-gu, South Korea
NCT04830345
- Conditions
- Glabellar Frown Lines
- Locations
-
- Nowon Eulji University Hospital Seoul, South Korea
Completed
The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines
NCT04996810
- Conditions
- Glabellar Frown Lines
- Locations
-
- Chung-Ang University Hospital Seoul, South Korea
- Nowon Eulji Medical Center Seoul, South Korea
Completed
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines
NCT04143815
- Conditions
- Glabellar Frown Lines
- Locations
-
- Maroubra MEdical Centre Maroubra, New South Wales, Australia
NCT03289169
- Conditions
- Glabellar Frown Lines
- Locations
-
- St. Paul Hospital Seoul, South Korea
NCT03837561
- Conditions
- Glabellar Frown Lines
- Locations
-
- Medical Center Capital-Health Moscow, Russia
NCT04281095
- Conditions
- Glabellar Frown Lines
- Locations
-
- Nowon Eulji Medical Center Seoul, South Korea
NCT02428608
- Conditions
- Glabellar Frown Lines
- Locations
-
- The Advanced Skin Research Center at Skin Specialists, PC Omaha, Nebraska, United States
Completed
Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines
NCT02184988
- Conditions
- Glabellar Frown Lines
- Locations
-
- ATS Clinical Research Santa Monica, California, United States